ExternalLinks

Pfizer hopes for a happy ending for an osteoarthritis drug with a troubled history

March 24, 2021

STAT

How the bitter political fight over painkillers could derail Biden's FDA pick

March 18, 2021

Politico

Policy Deciphered: Could FDA inspection backlog lead to approval slowdown?

March 11, 2021

Medical Marketing and Media

The Alzheimer's approval maze

March 11, 2021

pharma Manufacturing

Pandemic Forces F.D.A. to Sharply Curtail Drug Company Inspections

March 9, 2021

The New York Times

Alzheimer's Association Denies Conflict in Aducanumab Support

March 8, 2021

Medscape

Some retirement communities lure new residents with promise of Covid-19 vaccines

February 18, 2021

NBC News

Janet Woodcock slams calls for FDA 'firewall' amid aducanumab debacle, citing need for collaborative drug development

February 17, 2021

Endpoints News

After a controversial Alzheimer’s drug review, FDA’s Woodcock rejects proposal to ‘firewall’ agency review staff

February 16, 2021

STAT

Biogen Alzheimer’s Drug Puts FDA’s Judgment in Harsh Spotlight

January 30, 2021

Bloomberg

'What he is doing is outrageous': Doctors slam Sen. Ron Johnson over hearing on COVID-19 treatments

November 20, 2020

Milwaukee Journal Sentinel

Pfizer's COVID-19 Vax: A Good First Step, Say Experts — But questions remain and some criticize "science by press release"

November 9, 2020

MedPage Today

FDA’s own documents reveal agency’s lax, slow, and secretive oversight of clinical research

October 1, 2020

Science

Our Experts in the News